摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(+)-4-[8-chloro-6-(1-piperazinyl)-1H-benzo[5,6]cyclohepta[1,2-b]pyridine-11-yl]-1-(methylsulfonyl)piperidine

中文名称
——
中文别名
——
英文名称
(S)-(+)-4-[8-chloro-6-(1-piperazinyl)-1H-benzo[5,6]cyclohepta[1,2-b]pyridine-11-yl]-1-(methylsulfonyl)piperidine
英文别名
(11S)-8-Chloro-11-[1-(methylsulfonyl)piperidin-4-YL]-6-piperazin-1-YL-11H-benzo[5,6]cyclohepta[1,2-B]pyridine;(2S)-13-chloro-2-(1-methylsulfonylpiperidin-4-yl)-10-piperazin-1-yl-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
(S)-(+)-4-[8-chloro-6-(1-piperazinyl)-1H-benzo[5,6]cyclohepta[1,2-b]pyridine-11-yl]-1-(methylsulfonyl)piperidine化学式
CAS
——
化学式
C24H29ClN4O2S
mdl
——
分子量
473.039
InChiKey
ZMGCFGGMTCMSDP-QHCPKHFHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    32
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    73.9
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    5-bromo-8-chloro-11-(1-methanesulfonyl-piperidin-4-yl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine 在 potassium tert-butylate 作用下, 以 四氢呋喃 为溶剂, 生成 (S)-(+)-4-[8-chloro-6-(1-piperazinyl)-1H-benzo[5,6]cyclohepta[1,2-b]pyridine-11-yl]-1-(methylsulfonyl)piperidine
    参考文献:
    名称:
    Enhanced FTase activity achieved via piperazine interaction with catalytic zinc
    摘要:
    Benzocycloheptapyridine tricyclic compounds with piperazine or substituted piperidine moieties extending either from the 5- or 6-position of the tricyclic bridgehead exhibited enhanced FTase activity: this resulted from favorable binding of the ligand nitrogen with the catalytic zinc found in the FTase. A single isomer at C-11 with piperazine adduct extending from the 6-position, compound 24, exhibited excellent FTase activity with IC50 = 0.007 microM, soft agar IC50 = 72 nM, and Rat AUC(PO, 10 mpk) = 4.0 microM x h. X-ray of (-)-[8-chloro-6-(1-piperazinyl)-1H-benzo[5,6]]cyclohepta[1,2-b]pyridine-11-yl]-1-(methylsulfonyl)piperidine 24 bound to Ftase revealed favorable interaction between piperazine nitrogen and catalytic zinc atom.
    DOI:
    10.1016/j.bmcl.2005.10.090
点击查看最新优质反应信息

文献信息

  • IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS
    申请人:CAMP4 THERAPEUTICS CORPORATION
    公开号:US20210254056A1
    公开(公告)日:2021-08-19
    The present invention provides methods and compositions for the evaluation, alteration and/or optimization of gene signaling. Methods and systems are also provided which exploit the information generated in the identification of new targets and non-canonical signaling pathways.
  • Enhanced FTase activity achieved via piperazine interaction with catalytic zinc
    作者:F. George Njoroge、Bancha Vibulbhan、Patrick Pinto、Corey Strickland、W. Robert Bishop、Amin Nomeir、Vivyoor Girijavallabhan
    DOI:10.1016/j.bmcl.2005.10.090
    日期:2006.2
    Benzocycloheptapyridine tricyclic compounds with piperazine or substituted piperidine moieties extending either from the 5- or 6-position of the tricyclic bridgehead exhibited enhanced FTase activity: this resulted from favorable binding of the ligand nitrogen with the catalytic zinc found in the FTase. A single isomer at C-11 with piperazine adduct extending from the 6-position, compound 24, exhibited excellent FTase activity with IC50 = 0.007 microM, soft agar IC50 = 72 nM, and Rat AUC(PO, 10 mpk) = 4.0 microM x h. X-ray of (-)-[8-chloro-6-(1-piperazinyl)-1H-benzo[5,6]]cyclohepta[1,2-b]pyridine-11-yl]-1-(methylsulfonyl)piperidine 24 bound to Ftase revealed favorable interaction between piperazine nitrogen and catalytic zinc atom.
查看更多

同类化合物

马来酸阿扎他啶 脱羧氯雷他定杂质B 盐酸氯雷他定 盐酸氯雷他定 洛那法尼 氯雷他定脱氯杂质 氯雷他定环氧化物 氯雷他定杂质I 氯雷他定杂质F 氯雷他定杂质C 氯雷他定杂质50 氯雷他定杂质29 氯雷他定杂质26 氯雷他定杂质17 氯雷他定杂质14 氯雷他定杂质1 氯雷他定杂质 氯雷他定8-溴代杂质 氯雷他定 托吡林 富马酸卢帕他定 地氯雷他定杂质14 地氯雷他定杂质1 地氯雷他定异构体 地氯雷他定-D4 地氯雷他定 去氯雷他定-N-羟基哌啶 卢帕他定杂质C 卢帕他定杂质B 卢帕他定杂质2 卢帕他定杂质 卢帕他定 乙基4-[8-氯-4-(羟基甲基)-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基]-1-哌啶羧酸酯 乙基4-(8-氯-3-羟基-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基)-1-哌啶羧酸酯 乙基4-(8-氯-3-甲氧基-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基)-1-哌啶羧酸酯 乙基4-(8-氯-1-氧代-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基)-1-哌啶羧酸酯 [4-(8-氯-5,6-二氢-11H-苯并[5,6]环庚[1,2-b]吡啶基-11亚烷基)-1-哌啶基](1H-1,2,4-三唑-1-基)甲酮 N-甲酰基地氯雷他定 N-亚硝基地氯雷他定 N-乙酰基地氯雷他定 D3-3-氧代丁酸甲酯 8-脱氯-9-氯氯雷他定 8-脱氯-9-氯地氯雷他定 8-脱氯-9-氯-N-甲基地氯雷他定 8-氯-6,11-二氢-11-(4-哌啶基亚基)-5H-苯并[5,6]环庚三烯并[1,2-B]吡啶-2,3,4,5,5-D5 8-氯-6,11-二氢-11-(1-甲基-4-哌啶基)-5H-苯并[5,6]环庚烷[1,2-b]吡啶-11-醇 8-氯-6,11-二氢-11-(1-甲基-4-哌啶叉)-5H-苯并[5,6]环庚烷[1,2-b]吡啶 8-氯-5,6-二氢-11H-苯并[5,6]环庚烷并[1,2-b]吡啶-11-酮 8-氯-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-酮 1-氧化物 8-氯-3-甲氧基-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-酮